Schrödinger faces financial losses amid investment in experimental drugs. Key 2025 trial results will reveal its future ...
K.K. benefits from Japan’s cloud shift and strong profitability outlook. See why FREKF stock offers a solid long position ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果